
Consultant Pediatric Allergist at the Department of Pediatrics of the University of Padova, Italy

Professor of Medicine and Pediatrics; Chief of Clinical and Translational Research, University of South Florida, Tampa, United States

Professor at the University of Montreal and Sainte-Justine University Medical Centre at the Department of Pediatrics, Dermatology Division, Quebec, Canada

Janie Robinson and John Moore Lee Chair of Pediatrics and Director of Center for Pediatric Asthma Research | Vanderbilt University, Tennessee, United States

Chair of Pediatric Allergy-Immunology at the National Jewish Health, Professor of Pediatrics at the University of Colorado Denver School of Medicine, US

Professor | Department of Pediatric Gastroenterology and Hepatology | Clinic for Pediatrics and Adolescent Medicine | University Hospital Erlangen | Friedrich-Alexander University Erlangen-Nuremberg | Erlangen, Germany

Professor of Medicine | Associate Professor of Pediatrics in the Maternal and Child Health Department | Sapienza University of Rome; Consultant Pediatric Gastroenterologist | Umberto I University Hospital, Rome, Italy

Professor of Pediatrics | Perelman School of Medicine, University of Pennsylvania; Chief of Allergy Section and Director of the Center for Pediatric Eosinophilic Disorders | Children’s Hospital of Philadelphia, Pennsylvania, United States
Carolina Gutiérrez Junquera, MD, PhD, is an associate professor of Pediatrics at the Universidad Autónoma of Madrid, Spain, and a consultant pediatric gastroenterologist at University Hospital Puerta de Hierro Majadahonda in Madrid.

Chief of the Division of Pediatric Gastroenterology and Hepatology of the First Department of Pediatrics | National and Kapodistrian University of Athens; Head of the Gastroenterology Department | Children’s Hospital Agia Sofia, Athens, Greece
This page presents educational material, infographics, and video highlights from our recent ADVENT symposia, including the 2025 World Congress of Pediatric Dermatology (WCPD) in Buenos Aires, Argentina, exploring the pathophysiology of type 2 inflammation and atopic dermatitis, the burden of disease leading to cumulative life course impairment (CLCI), and the risk of the atopic march in pediatric patients with atopic dermatitis.

Many AD treatment goals focus on clinical manifestations, so that if a patient is free of lesions, their disease is considered well controlled. However, the inflammatory process underlying AD reaches far beyond the skin, affecting patients in unique ways at different stages of their lives. Education on the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient will help improve clinical management and reduce long-term patient burden.